Jack Markham retweeted
It's all things adamantane in our (@Lambert_Usyd) latest synthetic cannabinoid work, out now in @ACSChemNeurosci!
We synthesised and evaluated a library of adamantane-derived SCRAs, including fluorinated and deuterated analogues 🧪
🧵
pubs.acs.org/doi/10.1021/acs…
Jack Markham retweeted
More SCRA work from @Lambert_Usyd out now in @rsc_medchem!
We looked at a series of proteinogenic amino acid-derived SCRAs related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA, investigating the role of chirality in CB1 and CB2 receptor activation.
pubs.rsc.org/en/content/arti…
Jack Markham retweeted
Latest work from @Lambert_Usyd is online in @ACSChemNeurosci!
In another great collaboration with @christophestove et al., we looked at the recently detected synthetic cannabinoid ADB-HEXINACA and related analogues as emerging NPS🧪🔍
pubs.acs.org/doi/10.1021/acs…
Jack Markham retweeted
“You’ve got a bizarre situation in which you can grow opium poppies behind a farm fence, but if you grow cannabis you need [secure] facilities and dogs,” 🗨️ @iainsmcgregor
Read @JordsBaker's @smh feature on #medicalcannabis ft. the Lambert Initiative👐
smh.com.au/national/buying-l…
Jack Markham retweeted
Our latest paper from @Lambert_Usyd on 4-fluoro and 4-cyanobutyl substituted synthetic cannabinoids is online today!
tl;dr: most compounds assayed were moderate to high potency and efficacy CB1 agonists, and should be monitored as emerging NPS 🧪🔍
frontiersin.org/articles/10.…
Jack Markham retweeted
📚🤓 First Journal Club for 2022 @ LI, it's been a long time coming but now we can finally argue in person!
Ft. Maia yelling at @EA_Cairns, @MA_BEDOYAPEREZ, @TheCannabisGuyy, Ayshe, @JackMarkhamPhD, @eric_sparkes, Tom, Sam and @DuckyMcCartney 🥳
Jack Markham retweeted
#icrs2021 day 2. Late breaking research submission - Multiple overnight virtual conference attendance significantly increases snacking amongst academics. We’re (@Lambert_Usyd) on Twitter again, for all your questions 👩🔬🧑🔬👨🔬





